What’s Vulnerable › Vulnerabilities

CVE-2023-33365

• Severity: high (CVSS 7.5 v3.1)
• Exploited in the wild: not listed in CISA KEV
• EPSS: 0.7% probability of exploitation in the next 30 days
• Public exploit or detection template: none known
• Published: 2023-08-03 · updated 2026-06-17
• Weakness: CWE-22

Description

A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated attackers to fetch arbitrary files from the server's web server.

Affected products

• supremainc BioStar 2: before 2.9.1 — fixed in 2.9.1

How to fix

Upgrade to a fixed version: supremainc BioStar 2 2.9.1. Check the vendor advisory for mitigations.

References

• https://claroty.com/team82/disclosure-dashboard/cve-2023-33365
• https://kb.supremainc.com/knowledge/doku.php?id=en:release_note_291
• https://claroty.com/team82/disclosure-dashboard/cve-2023-33365
• https://kb.supremainc.com/knowledge/doku.php?id=en:release_note_291

Get alerted when CVE-2023-33365 or the next vulnerability affects your stack